GE HealthCare Technologies Inc Common Stock GEHC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GEHC is a good fit for your portfolio.
News
-
Super Micro and Nvidia lead the S&P 500 this year. These stocks follow.
-
Super Micro and Nvidia lead the S&P 500 this -2-
-
GE HealthCare announces cash dividend for second quarter of 2024
-
Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures
-
GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology
-
GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers
-
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
-
GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five...
Trading Information
- Previous Close Price
- $76.26
- Day Range
- $75.68–76.71
- 52-Week Range
- $62.35–94.50
- Bid/Ask
- $75.95 / $76.28
- Market Cap
- $34.84 Bil
- Volume/Avg
- 319 / 2.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 19.13
- Price/Sales
- 1.80
- Dividend Yield (Trailing)
- 0.16%
- Dividend Yield (Forward)
- 0.16%
- Total Yield
- 0.16%
Company Profile
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Mid Core
- Total Number of Employees
- 51,000
- Website
- https://www.gehealthcare.com
Comparables
Valuation
|
Metric
|
GEHC
|
CAJ
|
RDNT
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.13 | 21.58 | 73.31 |
Price/Book Value | 4.70 | 2.47 | 5.04 |
Price/Sales | 1.80 | 1.44 | 2.43 |
Price/Cash Flow | 16.56 | 9.06 | 14.81 |
Price/Earnings
GEHC
CAJ
RDNT
Financial Strength
|
Metric
|
GEHC
|
CAJ
|
RDNT
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.56 | 1.75 |
Current Ratio | 1.06 | 0.64 | 1.86 |
Interest Coverage | 5.25 | 2.10 | 1.85 |
Quick Ratio
GEHC
CAJ
RDNT
Profitability
|
Metric
|
GEHC
|
CAJ
|
RDNT
|
|---|---|---|---|
Return on Assets (Normalized) | 5.62% | 3.21% | 3.03% |
Return on Equity (Normalized) | 25.69% | 7.48% | 13.41% |
Return on Invested Capital (Normalized) | 12.70% | 5.67% | 6.05% |
Return on Assets
GEHC
CAJ
RDNT
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| Fcffnpsb | Wlkj | $29.6 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Dscqnv | $9.5 Bil | |||
| Solventum Corp
SOLV
| — | Ldxdx | $8.9 Bil | |||
| HealthEquity Inc
HQY
| — | Jlnnsq | $7.5 Bil | |||
| M3 Inc
MTHRF
| — | Jrgwgtb | $6.3 Bil | |||
| M3 Inc ADR
MTHRY
| — | Dcksrcf | $6.3 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Mqkfl | $5.9 Bil | |||
| Doximity Inc Class A
DOCS
| — | Jbwlpc | $5.0 Bil | |||
| R1 RCM Inc
RCM
| — | Fvdx | $4.6 Bil |